美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

SPDR S&P International Industria

34.71

0.0000

成交量：- -

成交額：- -

市值：2,082.60萬

市盈率：3.89

高：34.71

開：34.71

低：34.71

收：34.71

52周最高：34.71

52周最低：34.71

股本：60.00萬

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):8.93

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

益普生公佈2025年上半年強勁業績並上調全年財務指引

益普生2025年第一季度實現穩健業績增長並確認全年業績指引

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IPN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPN\",,,,,undefined,":{"symbol":"IPN","market":"US","secType":"STK","nameCN":"SPDR S&P International Industria","latestPrice":34.71,"timestamp":1757448000000,"preClose":34.71,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":600000,"eps":8.9298,"marketStatus":"盤前交易","change":0,"latestTime":"09-10 04:15:40 EDT","open":34.71,"high":34.71,"low":34.71,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.9298,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1757511000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":34.71,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPN\",,,,,undefined,":{"symbol":"IPN","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":600000,"dividePrice":0,"high":34.71,"amplitude":0,"preClose":34.71,"low":34.71,"week52Low":34.71,"pbRate":"--","week52High":34.71,"institutionHeld":0,"latestPrice":34.71,"eps":8.9298,"divideRate":0,"volume":0,"delay":0,"ttmEps":8.9298,"open":34.71,"prevYearClose":34.71,"prevWeekClose":34.71,"prevMonthClose":34.71,"prevQuarterClose":34.71,"fiveDayClose":34.71,"twentyDayClose":34.71,"sixtyDayClose":34.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-06-16","symbol":"IPN","amount":0.357922,"name":"SPDR S&P International Industria","recordDate":"2017-06-28","payableDate":"2017-06-20","currency":"USD","type":"dividend","dateTimestamp":1497585600000},{"market":"US","date":"2017-03-17","symbol":"IPN","amount":0.016732,"name":"SPDR S&P International Industria","recordDate":"2017-03-29","payableDate":"2017-03-21","currency":"USD","type":"dividend","dateTimestamp":1489723200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPN\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-29","value":0.016732,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-28","value":0.357922,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557399040","title":"益普生公佈2025年上半年強勁業績並上調全年財務指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2557399040","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557399040?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 12:32","pubTimestamp":1754368320,"startTime":"0","endTime":"0","summary":"在此基础上，我很高兴，益普生在销售和利润方面的全年指引做了上调。\" 2025年全年指引 基于上半年强劲的业绩表现，益普生上调了2025年全年财务指引：  以固定汇率计算，总销售额增长超过7.0%。2025年7月23日，欧盟委员会批准益普生将Cabometyx用于治疗既往接受治疗的晚期神经内分泌肿瘤患者。上述所有风险因素均可能影响益普生未来达成财务目标的能力，而这些目标是基于当前可获取信息并假设宏观经济环境相对稳定的前提下设定的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4744400_ZH44400_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4007","IPN","IPSEY"],"gpt_icon":0},{"id":"2528906912","title":"益普生2025年第一季度實現穩健業績增長並確認全年業績指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2528906912","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528906912?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 17:35","pubTimestamp":1744968900,"startTime":"0","endTime":"0","summary":"确认2025年全年财务指引。巴黎2025年4月18日 /美通社/ -- 全球特药领域生物制药公司益普生于4月16日公布了2025年第一季度的财务业绩。对益普生而言，2025年将是重要的一年，多个产品即将上市，我们的产品组合有望达成多项里程碑。\" 全年指引 益普生确认了2025年全年财务指引：  以固定汇率计算，总销售额增长超过5.0%。集团再融资 益普生于3月19日宣布成功完成其首次5亿欧元的评级公募债券发行，票面利率为3.875%，于2032年3月到期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4667912_ZH67912_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4007","IPSEY","IPN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}